OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 06, 2008
Also, Sartorius Stedim Biotech GmbH to acquire Wave Biotech; AstraZeneca's John Patterson to retire; more...
November 05, 2008
As offshore savings decline, pharmaceutical companies still have a lot of work to do to reduce costs.
November 02, 2008
This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.
Brief pharmaceutical news items for November 2008.
Despite challenges, contract manufacturers in Europe are enjoying considerable success.
Pharma companies could benefit from the lessons learned in this fall's financial crisis.
Pharmaceutical Technology will feature video coverage of AAPS this month.
November 01, 2008
More than 235 biotechnology companies call New Jersey home. They range from early start-ups with just a few employees to fully functioning companies with research, marketing and sales offices.
Although California remains the country's biotech leader, Michigan anticipates that the wind is shifting direction, albeit slowly
Richard Kilner, Managing Director of the Commonwealth of Pennsylvania European Investment Office, is incredibly enthusiastic about both his State and the potential it offers investors: "We are the number one State in pharmaceuticals (by number of establishments, employment and GDP output) and rapidly closing in on Massachusetts, the number two in biotech."